MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
EHAB stock logo

EHAB

Enhabit, Inc.

$13.8
0.01
 (0.07%)
Exchange:  NYSE
Market Cap:  706.913M
Shares Outstanding:  3.9M
Delayed data
Calculate EHAB Intrinsic Value
5-year outlook →
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Healthcare
Industry:  Medical – Care Facilities
   
CEO:  Barbara Ann Jacobsmeyer
Full Time Employees:  10600
Address: 
6688 N. Central Expressway
Dallas
TX
75206
US
Website:  https://www.ehab.com
Enhabit, Inc. operates as a U.S.-based provider of home healthcare and hospice services. Its comprehensive home health division offers various services, such as patient education, pain management, wound care (including dressing changes), cardiac rehabilitation, infusion therapy, pharmaceutical administration, and expert observation and assessment. The company specializes in managing chronic conditions like diabetes, hypertension, arthritis, Alzheimer’s disease, low vision, spinal stenosis, Parkinson’s disease, osteoporosis, complex wound care, and persistent pain. Additionally, Enhabit provides tailored disease-specific plans for individuals with diabetes, congestive heart failure, those recovering from orthopedic surgery or injuries, and patients with respiratory illnesses. Complementing these medical offerings, licensed physical, occupational, and speech therapists deliver vital rehabilitative support. Beyond home health, Enhabit delivers extensive hospice services designed to meet the physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. These services encompass pain and symptom control, palliative and dietary counseling, social worker visits, spiritual guidance, and bereavement support. As of March 31, 2022, Enhabit maintained a significant operational footprint, with 252 home health agencies and 99 hospice agencies spread across 34 states. Established in 2014 and headquartered in Dallas, Texas, the company was previously known as Encompass Health Home Health Holdings, Inc., officially rebranding to Enhabit, Inc. in March 2022. Enhabit, Inc. began operating as a completely independent entity on July 1, 2022.

Click to read more…

Revenue Segmentation

MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2025/05/11 — Q1 quarter 2025

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue1,046,3001,034,8001,060,000
Gross Profit510,700504,000497,300
EBITDA-16,500-83,60086,300
Operating Income-47,600-115,10063,800
Net Income-80,500-156,200-4,600

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets1,433,6001,226,0001,167,100
Total Liabilities731,900672,100603,000
Total Stockholders Equity669,700523,500534,000
Total Debt610,100569,500500,000
Cash and Cash Equivalents27,40028,40043,600

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow48,40051,20070,700
Capital Expenditure-3,500-3,800-4,900
Free Cash Flow44,90047,40065,800
Net Income-80,500-154,000-2,600
Net Change in Cash2,60050015,200

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2029Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)1,308,122.338Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)1,358,437.195Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)1,334,200Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)45,319.271Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)47,062.405Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)46,222.719Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)13,367.512Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)14,040.104Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)13,716Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)524,055.193Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)544,212.148Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)534,502.331Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)0.270Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)0.280Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)0.260Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)1Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)1Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
1.035B  ?P/S
 (TTM)
: 
0.66
?Net Income
 (TTM)
: 
-156200000  ?P/E
 (TTM)
: 
-220.8
?Enterprise Value
 (TTM)
: 
1.136B  ?EV/FCF
 (TTM)
: 
14.04
?Dividend Yield
 (TTM)
: 
0  ?Payout Ratio
 (TTM)
: 
0
?ROE
 (TTM)
: 
-0.01  ?ROIC
 (TTM)
: 
-0.02
?Net Debt
 (TTM)
: 
539.2M  ?Debt/Equity
 (TTM)
: 
0.87
?P/B
 (TTM)
: 
1.28  ?Current Ratio
 (TTM)
: 
1.56

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
23.00Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MARKETSnap estimates EHAB intrinsic value between $13.47 – $13.89 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.

[intrinsic_calculator]

Common questions about EHAB valuation

Is Enhabit, Inc. (EHAB) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Enhabit, Inc. (EHAB) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is EHAB a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether EHAB trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is EHAB’s P/E ratio?

You can see EHAB’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for EHAB?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is EHAB a good long-term investment?

Whether EHAB fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

EHAB

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

0.07
MARKETSnap

Trading Metrics:

Open: 13.79   Previous Close: 13.79
Day Low: 13.79   Day High: 13.81
Year Low: 6.47   Year High: 14.22
Price Avg 50: 13.76   Price Avg 200: 10.26
Volume: 652845   Average Volume: 1.653M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

Enhabit Home Health & Hospice Announces New Chief Executive Officer
18-05-2026 16:17
Enhabit Home Health & Hospice Announces New Chief Executive Officer
Fast-paced Momentum Stock Enhabit (EHAB) Is Still Trading at a Bargain
14-05-2026 09:55
Fast-paced Momentum Stock Enhabit (EHAB) Is Still Trading at a Bargain
Enhabit (EHAB) Upgraded to Buy: Here's Why
13-05-2026 13:01
Enhabit (EHAB) Upgraded to Buy: Here's Why
Enhabit Sets Stockholder Meeting Date of May 12, 2026, to Approve Transaction with Kinderhook
16-04-2026 16:15
Enhabit Sets Stockholder Meeting Date of May 12, 2026, to Approve Transaction with Kinderhook
Comparing Enhabit (NYSE:EHAB) & Selectis Health (OTCMKTS:GBCS)
25-03-2026 02:46
Comparing Enhabit (NYSE:EHAB) & Selectis Health (OTCMKTS:GBCS)
Hidden Gems for Nervous Investors: 4 Safe Haven Stocks Flying Below the Radar
10-03-2026 08:40
Hidden Gems for Nervous Investors: 4 Safe Haven Stocks Flying Below the Radar

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read